Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients

201579 citationsJournal Articlediamond Open Access

Authors

Rui Wang · Fudan University Shanghai Cancer Center

Yang Zhang · Fudan University Shanghai Cancer Center

Yunjian Pan · Fudan University Shanghai Cancer Center

Yuan Li · Shanghai Medical College of Fudan University

Haichuan Hu · Shanghai Medical College of Fudan University

Deng Cai · Fudan University Shanghai Cancer Center

Hang Li

Abstract

We determined the frequency of driver mutations in a large series of Chinese NSCLC patients. EGFR TKIs might improve the survival outcomes of EGFR-mutated lung adenocarcinoma patients who experienced disease recurrence.

Topics & Keywords

Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Oncotarget

Volume 6, Issue 33, pp. 34300-34308

DOI: 10.18632/oncotarget.5549

Field-Weighted Citation Impact: 7.43